Print Page | Contact Us | Report Abuse | Sign In | Join
Targeting Eosinophils: A Potent Contributor to Severe Asthma Hosted by Astrazeneca
Tell a Friend About This EventTell a Friend
 

Learning Objectives: This webinar will provide an overview of severe eosinophilic asthma and a biologic treatment option. The definition of severe asthma will be reviewed along with the features of “uncontrolled” asthma. The webinar will discuss the proportion of patients with eosinophilic asthma and will highlight key clinical indicators of eosinophilic asthma. The session will highlight a biologic treatment option for severe asthma and will address its indication, pharmacodynamics, pharmaco

6/23/2021
When: 6.23.2021
7:00 pm EST
Where: United States


Online registration is closed.
« Go to Upcoming Event List  

1120 Rte 73, Ste 200, Mt Laurel, NJ 08054

NOVA is professionally managed by Association Headquarters Inc., a charter accredited association management company.

© 2023 NOVA, Inc. All Rights Reserved.